Literature DB >> 16415487

Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there?

Voahanginirina Randriamboavonjy1, Ingrid Fleming.   

Abstract

Platelets express the endothelial form of the nitric oxide synthase (eNOS) and generate NO. However, in contrast to eNOS in endothelial cells, eNOS in platelets is largely Ca(2+)-independent and the activity is regulated by phosphorylation. Platelet-derived NO plays an important role in the regulation of platelet aggregation and secretion. Changes in the activity of platelet eNOS are responsible for the abnormal platelet activation encountered in different pathological situations (e.g. hypertension and diabetes). In this review, we will summarize the current knowledge of the role of platelet eNOS and the regulation of its activity as well as the fate of platelet-derived NO in physiological and pathological situations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16415487

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  10 in total

1.  Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes.

Authors:  Loredana Bergandi; Marco Cordero; Matteo Anselmino; Gaetana Ferraro; Laura Ravera; Paola Dalmasso; Corrado Moiraghi; Gian Paolo Trevi; Dario Ghigo; Amalia Bosia; Serena Bergerone
Journal:  Clin Res Cardiol       Date:  2010-05-14       Impact factor: 5.460

2.  Simvastatin increases the activity of endothelial nitric oxide synthase via enhancing phosphorylation.

Authors:  Xiaoxia Li; Peihua Wang; Xizhen Xu; Yong Wang; Yong Xia; Daowen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

3.  Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis.

Authors:  Katherine C Wood; Miriam M Cortese-Krott; Jason C Kovacic; Audrey Noguchi; Virginia B Liu; Xunde Wang; Nalini Raghavachari; Manfred Boehm; Gregory J Kato; Malte Kelm; Mark T Gladwin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

4.  The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets.

Authors:  Rodrigo Araújo Fraga-Silva; Sergio Veloso Brant Pinheiro; Andrey Christian Costa Gonçalves; Nathalia Alenina; Michael Bader; Robson Augusto Souza Santos
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

5.  Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Karel Tyml; Fuyan Li; John X Wilson
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

6.  Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats.

Authors:  Yi-Jin Ho; An-Sheng Lee; Wen-Pin Chen; Wei-Lung Chang; Ying-Kang Tsai; Hsi-Lin Chiu; Yueh-Hsiung Kuo; Ming-Jai Su
Journal:  Cardiovasc Diabetol       Date:  2014-06-12       Impact factor: 9.951

Review 7.  Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation.

Authors:  Tatiana E Suslova; Alexei V Sitozhevskii; Oksana N Ogurkova; Elena S Kravchenko; Irina V Kologrivova; Yana Anfinogenova; Rostislav S Karpov
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

Review 8.  Application of a nitric oxide sensor in biomedicine.

Authors:  Carlota Saldanha; José Pedro Lopes de Almeida; Ana Santos Silva-Herdade
Journal:  Biosensors (Basel)       Date:  2014-02-04

9.  Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.

Authors:  Alessandra Borgognone; Eduard Shantsila; Sophie M Worrall; Eakkapote Prompunt; Thomas Loka; Brodie L Loudon; Myriam Chimen; G Ed Rainger; Janet M Lord; Ashley Turner; Peter Nightingale; Martin Feelisch; Paulus Kirchhof; Gregory Y H Lip; Steve P Watson; Michael P Frenneaux; Melanie Madhani
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

10.  Thrombotic and Atherogenetic Predisposition in Polyglobulic Donors.

Authors:  Nikola Slaninova; Iveta Bryjova; Zenon Lasota; Radmila Richterova; Jan Kubicek; Martin Augustynek; Ayan Seal; Ondrej Krejcar; Antonino Proto
Journal:  Biomedicines       Date:  2022-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.